Cargando…

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma

BACKGROUND: Prognosis is a main factor affecting the survival of patients with lung adenocarcinoma (LUAD), yet no robust prognostic model of high effectiveness has been developed. This study is aimed at constructing a stable and practicable gene signature-based model via bioinformatics methods for p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yingqing, Zhang, Xiaoping, Lv, Xiaodong, Zhang, Ming, Gao, Xixi, Liu, Jialiang, Xu, Yufen, Fang, Zhixian, Chen, Wenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641279/ https://www.ncbi.nlm.nih.gov/pubmed/33195688 http://dx.doi.org/10.1155/2020/1836542

Ejemplares similares

Long Non-coding RNA HOXA11-AS Facilitates Proliferation of Lung Adenocarcinoma Cells via Targeting the Let-7c-5p/IGF2BP1 Axis
por: Lv, Xiaodong, et al.
Publicado: (2022)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9
por: Xu, Yufen, et al.
Publicado: (2022)

Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
por: Ling, Xiaodong, et al.
Publicado: (2023)

Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning
por: Wang, Qilong, et al.
Publicado: (2023)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma
por: Jin, Donghui, et al.
Publicado: (2020)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
por: Chen, Mingwei, et al.
Publicado: (2017)

A seven-lncRNA signature for predicting prognosis in breast carcinoma
por: Xu, Min, et al.
Publicado: (2021)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
por: Ma, Xiaoqing, et al.
Publicado: (2023)

Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma
por: Yao, Boyang, et al.
Publicado: (2021)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

The mitotic spindle-related seven-gene predicts the prognosis and immune microenvironment of lung adenocarcinoma
por: Shen, Ruxin, et al.
Publicado: (2023)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis
por: Li, Rang, et al.
Publicado: (2021)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma
por: Zou, Xuan, et al.
Publicado: (2020)

A Lipid Metabolism-Based Seven-Gene Signature Correlates with the Clinical Outcome of Lung Adenocarcinoma
por: Li, Tianqi, et al.
Publicado: (2022)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancer
por: Yufen, Xu, et al.
Publicado: (2016)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0s3aese3bjijl5qb2qlp7u878d